Generics

Bromfenac ophthalmic solution is a nonsteroidal anti-inflammatory drug indicated for postoperative inflammation in patients who have undergone cataract surgery.

Upsher-Smith was recognized in the Alliance Program Excellence category.

Bosutinib tablets are indicated for the treatment of Philadelphia chromosome-positive chronic myelogenous leukemia.

Zydus will market the product under the brand name Sigrima, while Dr. Reddy's will market it as Womab.

Ivosidenib Tablets, 250, mg have a market value of roughly $114 million for the 12 months ending March 2024, per IQVIA.

Pyzchiva is used to treat a range of conditions.

Omalizumab is used to treat a number of chronic conditions such as severe persistent allergic asthma.

Dabigatran etexilate capsules are a direct thrombin inhibitor indicated to reduce the risk of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation.